Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Executing Our Vision, Achieving Our Global Potential: A Letter to Shareholders

Dear Fellow Legible Shareholders, I want to thank you for your continued support, faith, and trust in the Legible team to execute on our vision to revolutionize the global eBook marketplace for readers, publishers, and authors through our innovative eBook entertainment pl...
Featured Submission | April 13, 2022 |

Valeo Pharma In-Play, New HesperCo™ Immune System Support Scientifically Demonstrated

Shares of Valeo Pharma Inc. (CSE: VPH) (Frankfurt: VP2) poised for substantial upside revaluation to reflect the major ‘company –maker’ potential in HesperCo™ as the market figures out it is set to be the subject of Covid-19 clinical trial. Valeo will benefit...
Fredrick William | September 2, 2020 |

This Cannabis Co. Earned a 100% Revenue Increase Over 3 Consecutive Quarters

(Click image to play video) Avicanna Inc. ( TSX: AVCN , OTCQX: AVCNF , Forum ) is a diversified and vertically integrated Canadian biopharmaceutical Company that is focused on the research, development, and commercialization of plant-derived cannabinoid-based products...
Featured Submission | April 20, 2021 |

Delta 9 CEO on Achieving Further Profits and Success in Cannabis

(Image via Delta 9 Cannabis) If you ask many cannabis operators how to achieve success in today’s market, you’d find it hard to get a confident reply. Yet Delta 9 Cannabis Inc. ( TSX:DN , OTC:VRNDF , Forum ) has been o...
Omri Wallach | December 9, 2019 |

Standard Lithium in Final Stages of De-risking New Recovery Method; ...

Standard Lithium in Final Stages of De-risking New Recovery Method; Giant JV Partner Lanxess Will Fully Fund Capex When Successful The Critical Investor delves into this lithium firm's recovery method for its Arkansas project and why it may succeed when other companie...
Streetwise Reports | September 26, 2019 |

ACCO Brands Shares Trade 15% Higher on Record Yearly Sales and Earnings

ACCO Brands Corp. traded higher after the company reported both record annual sales and adjusted earnings per share. Designer, manufacturer and marketer of branded academic, consumer and business products firm ACCO Brands Corp. (ACCO:NYSE) yesterday annou...
Streetwise Reports | February 13, 2020 |

eHealth Shares Rise 25% After Achieving 100% Increase in Quarterly Medicare Advantage Sales

Online medical exchange operator eHealth Inc.'s shares traded higher after the firm reported preliminary financial results for Q4/19 and FY/19. The company advised that both quarterly and annual revenues exceeded prior estimates. Private online health insurance exchan...
Streetwise Reports | January 27, 2020 |

Revolutionizing immunotherapies with groundbreaking DPX platform

The following is a transcription of the above video, and The Market Online has edited it for clarity . BioVaxys Technology Corp (CSE:BIOV) is a Canadian-based clinical stage biopharmaceutical company focused on improving patient lives with novel immunotherapies. CE...
Lyndsay Malchuk | July 30, 2024 |

Novamind Selected by Merck to Advance Research for Treatment-Resistant Depression

Novamind’s subsidiary, Cedar Clinical Research, to serve as a key clinical research site Independent validation of the expertise and capabilities of Novamind in managing clinical trials Adds to established track record conducting research a...
Featured Submission | March 18, 2021 |

Buzz on the Bullboards: The deep freeze

From coast-to-coast winter storms, the constant “sabre-rattling” between the world’s largest militaries, and the U.S. Supreme Court deciding whether it should essentially “upend the internet” as we know it, there...
Jonathon Brown | February 23, 2023 |
1 2 3 4 5 6 7 8 9 10 ...